Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/582,857, filed Nov 7, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,603,275 | Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 11,464,737 | Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 11,826,464 | Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 12,201,721 | Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| Application 18/999,928 | Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device Pending Not granted | Rani Therapeutics, LLC | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Rani Therapeutics, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.